People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

which involved around 800 patients treated with semaglutide or placebo on top of standard care and followed for 72 weeks. MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be fu ...

Research is still evolving to identify all the ways semaglutide can affect your overall health. Even so, it probably makes ...

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

Taking to his YouTube channel, scientist and medical director Dr William Li said there are five special kinds of drinks that he recommends to people with fatty liver disease. Dr Li is a world ...